Hemophilia A is treated with which clotting factor?

Study for the PaEasy Emergency Medicine Test. Prepare with detailed questions and explanations. Get ready to ace your exam!

Multiple Choice

Hemophilia A is treated with which clotting factor?

Explanation:
Factor VIII replacement is used to treat Hemophilia A because this condition stems from a deficiency of Factor VIII, a crucial cofactor in the intrinsic pathway that drives thrombin generation and proper clot formation. Replacing the missing Factor VIII restores the cascade’s function and allows fibrin to form normally, reducing bleeding. The other options address different conditions: Factor IX deficiency causes Hemophilia B, not A; Factor VII is part of the extrinsic pathway and isn’t the standard therapy for Hemophilia A; Von Willebrand factor is involved in von Willebrand disease and is not used to treat Hemophilia A (though some products may include it, the primary treatment for A is Factor VIII).

Factor VIII replacement is used to treat Hemophilia A because this condition stems from a deficiency of Factor VIII, a crucial cofactor in the intrinsic pathway that drives thrombin generation and proper clot formation. Replacing the missing Factor VIII restores the cascade’s function and allows fibrin to form normally, reducing bleeding. The other options address different conditions: Factor IX deficiency causes Hemophilia B, not A; Factor VII is part of the extrinsic pathway and isn’t the standard therapy for Hemophilia A; Von Willebrand factor is involved in von Willebrand disease and is not used to treat Hemophilia A (though some products may include it, the primary treatment for A is Factor VIII).

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy